HSBC Maintains Buy on Johnson & Johnson, Raises Price Target to $280

Benzinga Newsdesk www.benzinga.com Positive 89.3%

Neg 0% Neu 0% Pos 89.3%

HSBC analyst Morten Herholdt maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $265 to $280.